Table 2. Intra-Group comparisons of voiding parameters before and after treatment.
| Group 1 (n=34) | Group 2 (n=34) | |||||
|---|---|---|---|---|---|---|
| Before treatment | After treatment | p | Before treatment | After treatment | p | |
| 24-hour frequency (Mean ± SD) | 11.2 ± 2.1 | 7.7 ± 2.9 | <0.001 | 11.2 ± 2.0 | 9.0 ± 3.1 | 0.008 |
| Average voided volume, mL (Mean ± SD) | 252.2 ± 81.7 | 261.7 ± 77.5 | 0.622 | 261.4 ± 94.4 | 258.0 ± 82.0 | 0.815 |
| Qmax, mL/s, (Mean ± SD) | 11.0 ± 2.7 | 14.8 ± 2.6 | 0.001 | 11.1 ± 2.6 | 12.8 ± 2.9 | 0.005 |
| Qave, mL/s (Mean ± SD) | 6.0 ± 1.1 | 8.0 ± 1.0 | 0.001 | 6.0 ± 1.1 | 6.7 ± 1.1 | 0.007 |
| PVR, mL (Mean ± SD) | 83.2 ± 25.4 | 54.7 ± 31.5 | <0.001 | 82.7 ± 24.8 | 65.7 ± 24.1 | 0.005 |
| UDI-6 score (Median) | 13.5 | 9 | <0.001 | 13.5 | 12 | 0.002 |
| EMG activity, n (%) | 34 (100) | 14 (41.2) | 0.391† | 34 (100) | 22 (64.7) | 0.122† |
Qmax = maximum urine flow rate; Qave = average urine flow rate; PVR = Post-void residual urine volume; UDI-6 = Urogenital Distress Inventory; EMG = electromyography
†
Intergroup comparison was performed using the Chi-square test